CNR Institutional Research Information System

MANCA, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.732
NA - Nord America 735
EU - Europa 370
SA - Sud America 357
AF - Africa 34
OC - Oceania 4
Totale 3.232
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 827
US - Stati Uniti d'America 700
CN - Cina 314
BR - Brasile 295
HK - Hong Kong 228
VN - Vietnam 152
IT - Italia 137
NL - Olanda 82
KR - Corea 63
IN - India 36
DE - Germania 33
GB - Regno Unito 29
AR - Argentina 24
FI - Finlandia 18
ID - Indonesia 18
BD - Bangladesh 16
JP - Giappone 16
MX - Messico 16
AT - Austria 13
CA - Canada 13
IL - Israele 12
ZA - Sudafrica 12
IE - Irlanda 9
EC - Ecuador 8
IQ - Iraq 8
PL - Polonia 8
VE - Venezuela 8
SA - Arabia Saudita 7
UY - Uruguay 7
KE - Kenya 6
CO - Colombia 5
ES - Italia 5
FR - Francia 5
PY - Paraguay 5
RU - Federazione Russa 5
TR - Turchia 5
DZ - Algeria 4
MA - Marocco 4
PE - Perù 4
EG - Egitto 3
KZ - Kazakistan 3
NP - Nepal 3
PK - Pakistan 3
SE - Svezia 3
TN - Tunisia 3
AM - Armenia 2
AU - Australia 2
CZ - Repubblica Ceca 2
EE - Estonia 2
HU - Ungheria 2
JO - Giordania 2
LB - Libano 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
RO - Romania 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MW - Malawi 1
MY - Malesia 1
MZ - Mozambico 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 3.232
Salva come PNG Salva come JPEG
Città #
Singapore 474
Santa Clara 288
Hong Kong 228
Hefei 137
Beijing 87
Seoul 62
Ashburn 56
Ho Chi Minh City 52
San Jose 48
Dallas 47
Hanoi 38
Los Angeles 28
São Paulo 24
Cavallino 22
Cagliari 15
Guangzhou 13
New York 12
Rio de Janeiro 11
Düsseldorf 10
Dublin 9
Helsinki 9
Minamishinagawa 9
Vienna 9
Frankfurt am Main 8
Turku 8
Milan 7
Sala Baganza 7
Assemini 6
Belo Horizonte 6
Bengaluru 6
Campinas 6
Hải Dương 6
Jakarta 6
Montevideo 6
Munich 6
Nairobi 6
Orem 6
Phoenix 6
Tokyo 6
Amsterdam 5
Boardman 5
Buffalo 5
Denver 5
Johannesburg 5
Maceió 5
Montreal 5
Rome 5
Biên Hòa 4
Boston 4
Brooklyn 4
Curitiba 4
Da Nang 4
Genoa 4
Mumbai 4
Nuremberg 4
Porto Alegre 4
Quận Một 4
Riyadh 4
Salvador 4
Sassari 4
Thái Nguyên 4
Uberlândia 4
Warsaw 4
Cape Town 3
Dhaka 3
Florence 3
Franca 3
Guarulhos 3
Guayaquil 3
Ha Long 3
Haiphong 3
Hortolândia 3
Houston 3
Hyderabad 3
London 3
Manchester 3
Mexico City 3
Montes Claros 3
Naples 3
New Delhi 3
Philadelphia 3
Recife 3
San Francisco 3
Sorocaba 3
Tel Aviv 3
Volta Redonda 3
Amman 2
Araraquara 2
Asunción 2
Baghdad 2
Bandung 2
Bari 2
Betim 2
Blumenau 2
Bucharest 2
Buenos Aires 2
Bắc Giang 2
Cachoeirinha 2
Calgary 2
Caracas 2
Totale 1.991
Salva come PNG Salva come JPEG
Nome #
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 70
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 64
Il CSCC: aspetti distintivi della patologia 61
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 61
nalysis of Fanconi anemia genes in colorectal cancer. 58
Molecular Basis of open-angle glaucoma in Italy 58
Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma 58
Germline and somatic NGS-based analysis on BRCA-related tumors 58
Analysis of the oral microbiome during hormonal cycle and its alterations in menopausal women: the “AMICA” project 56
Role of argininosuccinate synthetase (ASS) expression in response to arginine deiminase (ADI) in melanoma cell lines 52
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 50
Molecular landscape profile of melanoma 49
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 49
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 48
Genetic Instability Markers in Cancer 47
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 47
Genetic alterations in main candidate genes during melanoma progression. 46
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 45
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 45
Origin of aneuploidy in relation to disturbances of cell-cycle progression. I. Effects of vinblastine on mouse bone marrow cells 43
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 43
Phenotype characterization of human melanoma cells resistant to Dabrafenib 42
Phenotype Characterization of Human Melanoma Cells Resistant to Dabrafenib. 41
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 40
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 40
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 40
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 38
A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome 37
Ngs-based analysis of atypical deep penetrating nevi 37
Idiopathic pulmonary fibrosis (IPF) and lung cancer 37
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 37
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches 36
Proteomic analysis in melanoma cell lines with different genotypes 34
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 34
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 33
Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells. 32
Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer 31
Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status 30
Proteomic Profiling of Human Melanoma Metastatic Cell Line Secretomes 30
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 30
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 30
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases 29
"Genomic instability of the human chromosome 10q25-q26 in patients with endometrial cancer". In New technologies for gynecologic and obstetric investigation. 4th Congress of the European society for gynecologic and obstetric investigation (1999) 28
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study 27
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 27
A refined physical and EST map spanning 7.4 Mb of 10q24, a region involved in neurological disorders 27
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 27
Low prevalence of microsatellite instability in malignant melanoma. 26
BRAF-NRAS mutation analysis among primary tumors and metastases at different sites from patients with melanoma 26
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 26
Detailed physical analysis of a 1.5-megabase YAC contig containing the MXI1 and ADRA2A genes 25
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 25
Long non-coding RNA CASC2 in human cancer 25
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 24
A novel candidate gene in human endometrial cancer at chromosome 10q26 24
Genetic alterations in main candidate genes during melanoma progression 24
Mutational analysis of candidate genes in families with malignant melanoma (MM): assessment of the role of the CDKN2A gene in MM predisposition. 23
Search for therapeutic response molecular markers in malignant melanoma through NGS: on the way to an anti-BRAF combination therapy. 23
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 23
Analysis of the MAPK-ERK gene Pathway in primary and metastatic melanoma cell lines 23
Low levels of genetic heterogeneity in matched lymph node metastases from melanoma patients 23
Molecular basis of open-angle glaucoma in Italy 22
Assessment of the progressive alterations in hepathic tumorigenesis through metabolic analysis. 22
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 22
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 22
Assesment of the role of Fanconi Anemia (FA) genes in colorectal cancer: A new pathogenetic pathway? 22
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 22
CORRELATION BETWEEN ARGINOSUCCINATE SYNTHETASE (ASS) EXPRESSION AND TREATMENT WITH ARGININE DEIMINASE (ADI) IN MELANOMA CELL LINES. 22
Expression of arginino-succinate synthetase (ASS) and response to arginine deiminase (ADI) treatment in a series of melanoma cell lines. AACR-NCI-EORTC 21
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma 21
Prevalence of BRAF and NRAS mutations in primary tumours and different types of metastasis among melanoma patients 21
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 21
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting of MLH1 and MSH2 inactivation in familial cases 21
Microsatellite Analysis at 10q25-q26 in Sardinian Patients with Sporadic Endometrial Carcinoma:Identification of Specific Patterns of Genetic Alteration 21
Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. 21
Mutation analysis of candidate genes in familial cases with malignant melanoma: identification of an additional susceptibility region at chromosome 9p21 21
Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. 21
A strategy for the selection of transcribed sequences in the Xq28 region 20
Sequential accumulation of molecular alterations at the chromosome 9p21 during development and progression of melanoma. 20
Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and the female gonad 20
Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets 20
Genetic and epigenetic alterations of mismatch repair genes in endometrial and colorectal carcinomas 20
Cytogenetic assesment of the involvement of a new locus at 9p21 in malignant melanoma. 19
Epidemiological and genetic factors underlying melanoma development in Italy 19
CASC2a gene is downregulated in endometrial cancer. 19
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 19
Discrepant alterations in main candidate genes among multiple primary melanomas 19
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup study 19
Evaluation of genetic heterogeneity in paired lymph node metastases from melanoma patients using next-generation sequencing (NGS) approaches 19
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 19
Germline mutations in Brca1 and Brca2 genes among Sardinian breast cancer patients 18
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 18
TRANSGENIC MOUSE - AN INVIVO SYSTEM FOR DETECTION OF ANEUGENS 18
Progressive alterations at chromosome 9P21 in melanomagenesis 18
BRCA1 and BRCA2 mutation analysis through an evaluation clinic program among Sardinian breast cancer patients. 18
Mutation analysis of HMLH1-HMSH2 genes among Sardinian patients with sporadic and familial colorectal cancer 18
BRAF, NRAS and p16CDKN2A, mutations among primary and secondary melanomas from same patients 18
Role on the BRAF gene in malignant melanoma 18
Proteomics and expression analysis for identification of new candidate genes in melanoma progression 17
null 17
Totale 3.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.867
article - articoli 9.164
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 602
Totale 21.633
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202428 0 0 0 0 0 0 0 0 5 0 15 8
2024/20251.631 17 6 98 64 294 77 29 98 66 100 382 400
2025/20261.652 137 201 261 337 512 124 80 0 0 0 0 0
Totale 3.311